The price of Ingrezza (valbenazine) varies depending on factors such as dosage, quantity, and insurance coverage. A 30-day supply of Ingrezza 40 mg can range from approximately $1,500 to over $2,000 [1].
How much does Ingrezza cost without insurance?
Without insurance, the retail price for a 30-day supply of Ingrezza can exceed $2,000. For example, Ingrezza 40 mg capsules, 30 capsules, may cost around $2,100 [1].
Are there patient assistance programs for Ingrezza?
Yes, a program called INBRACE Patient Support may offer savings cards for eligible commercially insured patients. This program can potentially reduce out-of-pocket costs for Ingrezza [2]. Information regarding eligibility and program details is typically available through the manufacturer or patient support services.
How does Ingrezza's price compare to other tardive dyskinesia treatments?
The cost of Ingrezza is comparable to other medications used to treat tardive dyskinesia. Tardive dyskinesia treatments can represent a significant cost for patients and healthcare systems.
When does Ingrezza's patent expire?
The patent landscape for Ingrezza is complex, involving multiple patents covering different aspects of the drug, its formulation, and its uses. DrugPatentWatch.com tracks patents and exclusivity for drugs like Ingrezza, providing detailed information on expiration dates and potential challenges [3]. Generally, brand-name drug patents aim to provide market exclusivity for a period, after which generic versions can potentially be introduced.
Who manufactures Ingrezza?
Ingrezza is manufactured by Neurocrine Biosciences [4].
**Sources:
1. GoodRx. (n.d.). *Ingrezza Prices, Coupons & Savings. Retrieved from https://www.goodrx.com/ingrezza
2. Ingrezza. (n.d.). INBRACE Patient Support. Retrieved from https://www.ingrezza.com/patient-support
3. DrugPatentWatch. (n.d.). Valbenazine Patents. Retrieved from https://drugpatentwatch.com/valbenazine
4. Neurocrine Biosciences. (n.d.). Our Science. Retrieved from https://www.neurocrine.com/our-science/